Pharmaceuticals - Community Register

  

Community register of medicinal products for human use


AUTHORISED  

Product information

Invented name: DuoTrav   
Auth. number : EU/1/06/338
INN : Travoprost / Timolol
ATC: Anatomical main group: S - Sensory organs
Therapeutic subgroup: S01 - Ophthalmologicals
Pharmacological subgroup: S01E - Antiglaucoma preparations and miotics
Chemical subgroup: S01ED - Beta blocking agents
Chemical substance: S01ED51 - Timolol, combinations
(See WHO ATC Index)
Indication: Decrease of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues
Marketing Authorisation Holder: Alcon Laboratories (UK) Ltd.
Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom

  EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which continues to be available in the Community Register.

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
26/04/2006 Centralised - Authorisation EMEA/H/C/665 (2006)1753 of 24/04/2006
13/09/2006 Centralised - Variation EMEA/H/C/665/IB/2
05/12/2006 Centralised - Variation EMEA/H/C/665/IB/3
09/02/2007 Centralised - Variation EMEA/H/C/665/N/4
Updated with Decision(2008)1278 of 31/03/2008
08/08/2007 Centralised - Variation EMEA/H/C/665/II/5
12/12/2007 Centralised - Variation EMEA/H/C/665
02/04/2008 Centralised - Variation EMEA/H/C/665/II/7 (2008)1278 of 31/03/2008
05/08/2008 Centralised - Variation EMEA/H/C/665/II/9 (2008)4282 of 31/07/2008
23/09/2008 Centralised - Variation EMEA/H/C/665/IB/10
07/10/2008 Centralised - Variation EMEA/H/C/665/IA/11
04/02/2009 Centralised - Variation EMEA/H/C/665/II/12 (2009)731 of 02/02/2009
04/03/2009 Centralised - Variation EMEA/H/C/665/IB/14
04/03/2009 Centralised - Variation EMEA/H/C/665/IB/15
08/01/2010 Centralised - Variation EMEA/H/C/665/II/16
09/04/2010 Centralised - Variation EMEA/H/C/665/IB/17
14/09/2010 Centralised - Variation EMEA/H/C/665/IG/19
11/10/2010 Centralised - Renewal EMEA/H/C/665/R/18 (2010)7083 of 07/10/2010
18/01/2011 Centralised - Variation EMEA/H/C/665/IG/39
Updated with Decision(2011)2103 of 24/03/2011
23/03/2011 Centralised - Variation EMEA/H/C/665/IA/20
29/03/2011 Centralised - Variation EMEA/H/C/665/II/19/G (2011)2103 of 24/03/2011
17/02/2012 Centralised - Variation EMEA/H/C/665/IB/26
Updated with Decision(2012)7156 of 08/10/2012
10/10/2012 Centralised - Variation (2012)7156 of 08/10/2012
19/03/2013 Centralised - Variation EMEA/H/C/665/IG/274
Updated with Decision(2014)2058 of 21/03/2014
01/07/2013 Centralised - Variation EMEA/H/C/665/N/32
Updated with Decision(2014)2058 of 21/03/2014
25/07/2013 Centralised - Variation EMEA/H/C/665/II/31
Updated with Decision(2014)2058 of 21/03/2014
22/01/2014 Centralised - Variation EMEA/H/C/665/N/36
Updated with Decision(2014)2058 of 21/03/2014
25/03/2014 Centralised - Variation (2014)2058 of 21/03/2014